✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium–glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus

✍ Scribed by S. Kasichayanula; M. Chang; M. Hasegawa; X. Liu; N. Yamahira; F. P. LaCreta; Y. Imai; D. W. Boulton

Book ID: 118712573
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 705 KB
Volume: 13
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2011.01359.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Pharmacokinetics and Pharmacody

Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2

✍ Kasichayanula, Sreeneeranj; Liu, Xiaoni; LaCreta, Frank; Griffen, Steven C.; Bou 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 522 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

✍ Devineni, Damayanthi; Curtin, Christopher R.; Polidori, David; Gutierrez, Maria 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 605 KB

Dapagliflozin: A Novel Sodium-Glucose Co

Dapagliflozin: A Novel Sodium-Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

✍ Niren K. Shah; Wasim E. Deeb; Rushab Choksi; Benjamin J. Epstein 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Development of the sodium-glucose co-tra

Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus

✍ Gerich, John E; Bastien, Arnaud 📂 Article 📅 2011 🏛 Expert Reviews 🌐 English ⚖ 976 KB

Safety, Pharmacokinetic, and Pharmacodyn

Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Type 2 Diabetes Mellitus

✍ Schwartz, Sherwyn L.; Akinlade, Bola; Klasen, Sally; Kowalski, Donna; Zhang, Wen 📂 Article 📅 2011 🏛 Mary Ann Liebert 🌐 English ⚖ 322 KB

Safety, pharmacokinetics and pharmacodyn

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus

✍ Elizabeth K Hussey, Anita Kapur, Robin O’Connor-Semmes… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 291 KB